Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hereditary angioedema+1

Recruiting

Investigational

A study of navenibart for long-term safety in patients with hereditary angioedema

Investigational

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:NAVENIBART

Contact Research Centre

Hereditary angioedema

Recruiting

Investigational

Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:ADX-324

Contact Research Centre

Hereditary angioedema

Recruiting

InvestigationalNo placebo

A study of donidalorsen for children with hereditary angioedema

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Donidalorsen

Contact Research Centre

Hereditary angioedema

Recruiting

Investigational

A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:ADX-324

Contact Research Centre

Hereditary angioedema

Recruiting

InvestigationalNo placebo

Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents

InvestigationalNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deucrictibant

Contact Research Centre

Hereditary angioedema

Recruiting

Registered drugNo placebo

Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Berotralstat

Contact Research Centre

Hereditary angioedema+1

Recruiting

Registered drug

Study on C1 Esterase Inhibitor for Treating and Preventing Hereditary Angioedema Attacks in Patients with C1-INH Deficiency

Registered drug

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Hereditary angioedema

Recruiting

InvestigationalNo placebo

Long-Term Safety Study of NTLA-2002 for Patients with Hereditary Angioedema, Using Messenger RNA Encoding Cas9 and HU-G012267

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lonvoguran

Contact Research Centre

Hereditary angioedema+1

Not recruiting

Investigational

Study of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema

Investigational

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:NAVENIBART

Contact Research Centre

Hereditary angioedema

Not recruiting

InvestigationalNo placebo

Safety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Garadacimab

Contact Research Centre

Hereditary angioedema

Not recruiting

InvestigationalNo placebo

Study on the Effect and Safety of BW-20805 for Adults with Hereditary Angioedema

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:BW-20805

Contact Research Centre

Hereditary angioedema

Not recruiting

Registered drug

Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lonvoguran

Contact Research Centre

Find therapies in clinical trials near you

22 trials match your criteria

Hereditary angioedema+1

A study of navenibart for long-term safety in patients with hereditary angioedema

Hereditary angioedema

Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

Hereditary angioedema

A study of donidalorsen for children with hereditary angioedema

Hereditary angioedema

A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

Hereditary angioedema

Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents

Hereditary angioedema

Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

Hereditary angioedema+1

Study on C1 Esterase Inhibitor for Treating and Preventing Hereditary Angioedema Attacks in Patients with C1-INH Deficiency

Hereditary angioedema

Long-Term Safety Study of NTLA-2002 for Patients with Hereditary Angioedema, Using Messenger RNA Encoding Cas9 and HU-G012267

Hereditary angioedema+1

Study of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema

Hereditary angioedema

Safety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema

Hereditary angioedema

Study on the Effect and Safety of BW-20805 for Adults with Hereditary Angioedema

Hereditary angioedema

Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.